LakeShore Biopharma Co., Ltd s (LSBPW) SEC News Oct. 29, 2025, 12:05 UTC 2 0 comments New Form SCHEDULE 13D/A - LakeShore Biopharma Co., Ltd. Filed: 2025-10-29 AccNo: 0001213900-25-103261 Size: 392 KB Comment Full text
BioSig Technologies Inc. (BSGM) SEC News Oct. 29, 2025, 12:00 UTC 2 1 comments (99% Neutral) STREAMEX CORP. (BSGM) Announces Business Combination Comment Full text
Nuvectis Pharma Inc (NVCT) SEC News Oct. 29, 2025, 12:00 UTC 2 1 comments Mosseri Marlio Charles 🟢 acquired 154.8K shares of Nuvectis Pharma, Inc. (NVCT) at $6.28 Transaction Date: Oct 23, 2025 | Filing ID: 103522 Comment Full text
Ikena Oncology (IKNA) SEC News Oct. 29, 2025, 12:00 UTC 2 1 comments (99% Neutral) IMAGENEBIO, INC. (IKNA) Announces Business Combination Comment Full text
Recursion Pharmaceuticals Inc (RXRX) SEC News Oct. 29, 2025, 11:59 UTC 2 1 comments (99% Neutral) RECURSION PHARMACEUTICALS, INC. (RXRX) Announces Business Combination Comment Full text
Fortive Corp (FTV) SEC News Oct. 29, 2025, 11:42 UTC 2 0 comments New Form 10-Q - Fortive Corp Filed: 2025-10-29 AccNo: 0001659166-25-000131 Size: 8 MB Comment Full text
Purple Biotech Ltd. (PPBT) SEC News Oct. 29, 2025, 11:34 UTC 2 1 comments (85% Positive) Purple Biotech Ltd. (PPBT) Announces Clinical Development Update (Form 6-K) Comment Full text
Fortive Corp (FTV) SEC News Oct. 29, 2025, 11:34 UTC 1 1 comments (100% Positive) Fortive Corporation (FTV) Reports Q4 2025 Financial Results Comment Full text
Fulcrum Therapeutics (FULC) SEC News Oct. 29, 2025, 11:11 UTC 2 0 comments New Form 10-Q - Fulcrum Therapeutics, Inc. Filed: 2025-10-29 AccNo: 0001193125-25-254633 Size: 10 MB Comment Full text
Amarin Corporation Plc (AMRN) SEC News Oct. 29, 2025, 11:06 UTC 3 0 comments New Form 10-Q - AMARIN CORP PLC\UK Filed: 2025-10-29 AccNo: 0001193125-25-254621 Size: 12 MB Comment Full text